Drug Delivery News and Research

RSS

Drug delivery is a term that refers to the delivery of a pharmaceutical compound into the body. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Much research is now focussing on nanotechnology as a drug delivery method.

OptiNose chooses BioClinica's advanced imaging and IWR solutions for clinical trials

BioClinica, Inc., a global provider of clinical trial management solutions, today announced that OptiNose, Inc. selected BioClinica Trident IWR, Optimizer clinical supplies forecasting, and Imaging Core Lab services for use in a series of clinical trials including several pivotal Phase III studies.

From Clario 8 Sep 2011

Scientists invent new system that uses magnetism to purify hybrid nanoparticles

A team of Penn State University scientists has invented a new system that uses magnetism to purify hybrid nanoparticles -- structures that are composed of two or more kinds of materials in an extremely small particle that is visible only with an electron microscope.

8 Sep 2011

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

BioDelivery Sciences International, Inc. announced positive preliminary results from its Phase 1 study assessing the pharmacokinetics of a BEMA Buprenorphine/Naloxone formulation.

6 Sep 2011

Discovery Labs files Complete Response to FDA for SURFAXIN to treat RDS in premature infants

Discovery Labs, Inc. today announced that, on September 2, 2011, it submitted its Complete Response to the 2009 Complete Response Letter issued by the U.S. Food and Drug Administration (FDA) for SURFAXIN(lucinactant) for the prevention of respiratory distress syndrome (RDS) in premature infants.

6 Sep 2011

ICS, Quintiles enter agreement with Pacira to support launch of EXPAREL

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that it has entered into agreements with Quintiles Commercial US, Inc. and Integrated Commercialization Services, Inc. (ICS) to support the anticipated launch of EXPAREL, should it be approved by the Food and Drug Administration (FDA) later this year.

6 Sep 2011

Berlin to market wide range of Acino Pharma's current and future products in Thailand

Berlin Pharmaceutical Industry Co., Ltd. and Acino Pharma AG signed a long term partnership agreement under which Berlin will market a wide range of the Swiss company's current and future products in Thailand.

5 Sep 2011

ORTHOCON signs license deal to develop, commercialize Bezwada's technology for bone applications

ORTHOCON, Inc., a privately-held therapeutic device company, today announced the signing of an exclusive, worldwide license agreement with Bezwada Biomedical to develop and commercialize Bezwada's technology for bone applications.

31 Aug 2011

Positive results from Pearl's formoterol fumarate MDI Phase 2b trial on moderate-to-severe COPD

Pearl Therapeutics Inc. today announced positive results from a randomized, double-blind, Phase 2b, dose-ranging study of its formoterol fumarate metered dose inhaler (FF MDI; PT005), a long-acting beta-2 agonist (LABA) compared to placebo and Foradil Aerolizer in patients with moderate-to-severe COPD.

31 Aug 2011

Sutureless method for reconnecting blood vessels

Reconnecting severed blood vessels is mostly done the same way today - with sutures - as it was 100 years ago, when the French surgeon Alexis Carrel won a Nobel Prize for advancing the technique.

29 Aug 2011

Baxter enters definitive agreement to acquire Baxa

Baxter International Inc. announced today that it has entered into a definitive agreement to acquire Baxa Corporation, a privately held company based in Englewood, Colo., with additional operations in Florida and the United Kingdom.

From Baxter International Inc. 25 Aug 2011

New Pressurized Olfactory Device shows direct CNS effect of morphine

A simple new approach to nasal drug administration may allow morphine and other strong pain medications to be targeted directly to the central nervous system (CNS), reports an experimental study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

24 Aug 2011

Pearl selects TransPerfect's Trial Interactive eTMF solution for clinical development programs

TransPerfect today announced that Pearl Therapeutics has implemented TransPerfect's Trial Interactive electronic Trial Master File (eTMF) solution for the company's clinical development programs.

23 Aug 2011

NovaDel, Rechon enter license and distribution agreement for Zolpimist

NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

23 Aug 2011

Antigen Express provides update on ongoing AE37 Phase 2 trial in breast cancer

Generex Biotechnology Corporation announced today that the Company's wholly-owned subsidiary Antigen Express, Inc. presented an update of the ongoing Phase 2 trial with an off-the-shelf immunotherapeutic cancer vaccine, AE37, in patients with breast cancer at Cambridge Healthtech Institute's Sixth Annual ImVacS: The Immunotherapeutics and Vaccine Summit held August 16-18, 2011 in Cambridge, MA.

19 Aug 2011

Pittsburgh researchers combine Viscotek GPC and Zetasizer Nano in work on novel polymers for drug delivery

Molecular weight and molecular weight distribution measurements are a basic necessity in studying the synthesis of the novel polymers being carried out by researchers at the Department of Bioengineering at the University of Pittsburgh. For the Pittsburgh team, the applications and technical expertise provided by Malvern Panalytical is a significant factor in their use of the company’s Viscotek gel permeation chromatography (GPC) system to characterize polymer molecular weight, prior to applying the Zetasizer Nano for zeta potential measurements to study inter-molecular interactions.

From Malvern Panalytical 18 Aug 2011

NCRM at Case Western Reserve to host stem cell conference in Cleveland

The National Center for Regenerative Medicine (NCRM) at Case Western Reserve University is proud to present "MSC 2011: Innovations in Cell-Based Regenerative Therapies," a three-day forum to highlight transformative breakthroughs in the area of adult stem cell medicine with a focus on how this research is being applied in patient care settings through innovative clinical trials.

18 Aug 2011

HSS, pSivida enter orthopedic evaluation agreement

Drug delivery company pSivida Corp. today announced it has entered into an evaluation agreement with Hospital for Special Surgery (HSS), a world leader in orthopedics, rheumatology and rehabilitation, to investigate pSivida's drug delivery technologies in orthopedics.

17 Aug 2011

BD acquires Carmel Pharma

BD, a leading global medical technology company, today announced the completion of its acquisition of Carmel Pharma, AB, a Swedish company that manufactures the PhaSeal® System, the leading closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials.

From BD (Becton, Dickinson and Company) 17 Aug 2011

Echo net loss for first half 2011 increases to $6.5 million

Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude SkinPrep System for transdermal drug delivery, today announced results for the period ended June 30, 2011.

12 Aug 2011

Soligenix second quarter revenues decrease to $406,000

Soligenix, Inc., a late-stage biopharmaceutical company, announced today its financial results for the second quarter of 2011.

12 Aug 2011

Drug Delivery News and Research

Further Reading

OptiNose chooses BioClinica's advanced imaging and IWR solutions for clinical trials

Scientists invent new system that uses magnetism to purify hybrid nanoparticles

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

Discovery Labs files Complete Response to FDA for SURFAXIN to treat RDS in premature infants

ICS, Quintiles enter agreement with Pacira to support launch of EXPAREL

Berlin to market wide range of Acino Pharma's current and future products in Thailand

ORTHOCON signs license deal to develop, commercialize Bezwada's technology for bone applications

Positive results from Pearl's formoterol fumarate MDI Phase 2b trial on moderate-to-severe COPD

Sutureless method for reconnecting blood vessels

Baxter enters definitive agreement to acquire Baxa

New Pressurized Olfactory Device shows direct CNS effect of morphine

Pearl selects TransPerfect's Trial Interactive eTMF solution for clinical development programs

NovaDel, Rechon enter license and distribution agreement for Zolpimist

Antigen Express provides update on ongoing AE37 Phase 2 trial in breast cancer

Pittsburgh researchers combine Viscotek GPC and Zetasizer Nano in work on novel polymers for drug delivery

NCRM at Case Western Reserve to host stem cell conference in Cleveland

HSS, pSivida enter orthopedic evaluation agreement

BD acquires Carmel Pharma

Echo net loss for first half 2011 increases to $6.5 million

Soligenix second quarter revenues decrease to $406,000

Must Know Trends for Drug Delivery Systems and the Crucial Role of Materials Testing eBook eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo